002750.SZ Stock Analysis
00
Uncovered
Kunming Longjin Pharmaceutical Co Ltd is uncovered by Eyestock quantitative analysis.
Rating
To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.
Low score
Kunming Longjin Pharmaceutical Co., Ltd. engages in the development, manufacture, and sale of natural herbal and chemical freeze-dried medicines. The company is headquartered in Kunming, Yunnan and currently employs 517 full-time employees. The company went IPO on 2015-03-24. The firm's products cover traditional Chinese medicine, biochemical medicine and chemical medicine, which including cardio-cerebral vascular medicine, digestive system medicine, immune system medicine, vitamins, mineral enteral and parenteral nutrition medicines. The main products of which is breviscapine injection. The firm conducts its businesses primarily within the domestic market.